Bianchi, Antonio
 Distribuzione geografica
Continente #
EU - Europa 564
NA - Nord America 501
AS - Asia 90
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.160
Nazione #
US - Stati Uniti d'America 500
DE - Germania 279
SE - Svezia 90
UA - Ucraina 67
CN - Cina 61
IT - Italia 25
IE - Irlanda 24
GB - Regno Unito 21
FR - Francia 20
IN - India 14
FI - Finlandia 13
RU - Federazione Russa 9
SG - Singapore 9
BE - Belgio 6
CI - Costa d'Avorio 2
IL - Israele 2
NL - Olanda 2
PL - Polonia 2
TR - Turchia 2
AL - Albania 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
ES - Italia 1
EU - Europa 1
JP - Giappone 1
KR - Corea 1
MD - Moldavia 1
ME - Montenegro 1
RO - Romania 1
Totale 1.160
Città #
Chandler 130
Ashburn 37
Ann Arbor 30
Jacksonville 25
San Mateo 25
Dublin 24
Dearborn 17
Houston 15
Nanjing 15
Wilmington 13
New York 12
Nürnberg 12
Boston 11
Marseille 10
Fremont 9
Woodbridge 9
Princeton 7
Seattle 7
Brussels 6
Detroit 6
Mountain View 6
Boardman 5
Lawrence 5
Nanchang 5
Shenyang 5
Singapore 5
Zhengzhou 5
Beijing 4
Cattolica 4
Fairfield 4
Kunming 4
Pune 4
Bremen 3
Cambridge 3
Changsha 3
Hebei 3
Jiaxing 3
Los Angeles 3
Milan 3
Moscow 3
Munich 3
Redwood City 3
University Park 3
Ypsilanti 3
Abidjan 2
Brescia 2
Changchun 2
Chicago 2
Cornaredo 2
Fort Worth 2
Hangzhou 2
Helsinki 2
Henderson 2
Indiana 2
Izmir 2
Leawood 2
Palermo 2
Szewce 2
Turin 2
Utrecht 2
Addison 1
Andover 1
Augusta 1
Bergamo 1
Berlin 1
Chisinau 1
Costa Mesa 1
Edinburgh 1
Forest City 1
Hefei 1
Lancaster 1
Manchester 1
Miami 1
Motru 1
Napoli 1
Ningbo 1
Norwalk 1
Nuremberg 1
Philadelphia 1
Podgorica 1
Portland 1
Quzhou 1
San Francisco 1
Seoul 1
Simi Valley 1
Southend 1
Stockholm 1
Taizhou 1
Tappahannock 1
Tianjin 1
Toronto 1
Vancouver 1
Vlorë 1
Washington 1
Yaroslavl 1
Totale 579
Nome #
The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel 215
Seminal antioxidant capacity in pre- and postoperative varicocele 158
Isolated growth hormone deficiency: clinical entity? 100
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 99
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. 96
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 88
Increased total antioxidant capacity in seminal plasma of varicocele patients: a multivariate analysis 78
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 72
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: THE NET MANAGEMENT STUDY 71
Prevalence of vertebral fractures in men with acromegaly 67
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. 65
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 56
Totale 1.165
Categoria #
all - tutte 3.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020166 31 16 11 2 9 12 29 6 12 6 22 10
2020/2021127 8 13 8 9 12 16 13 5 15 10 18 0
2021/2022141 12 13 2 10 6 6 4 22 4 8 20 34
2022/2023314 45 50 22 51 20 37 15 28 37 1 7 1
2023/202497 6 32 1 4 4 19 3 3 1 3 9 12
Totale 1.165